Benzinga | Apr 28, 2021 08:45AM EDT

Allen Institute and BioMarin Team Up To Develop Gene Therapies For Rare Brain Diseases

The Allen Institute and BioMarin Pharmaceutical Inc. announced a collaboration today that will use technologies developed at the Allen Institute to create new gene therapies aimed at rare genetic diseases of the central nervous system. BioMarin will receive an exclusive license to each program for research, development and commercialization. The organizations did not disclose financial terms.